Schinke Thorsten, Liese Sarah, Priemel Matthias, Haberland Michael, Schilling Arndt F, Catala-Lehnen Philip, Blicharski Dagmar, Rueger Johannes M, Gagel Robert F, Emeson Ronald B, Amling Michael
Department of Trauma, Hand, and Reconstructive Surgery, Hamburg University School of Medicine, Martinistrasse 52, Hamburg 20246, Germany.
J Bone Miner Res. 2004 Dec;19(12):2049-56. doi: 10.1359/JBMR.040915. Epub 2004 Sep 20.
We recently described an unexpected high bone mass phenotype in mice lacking the Calca gene that encodes CT and alphaCGRP. Here we show that mice specifically lacking alphaCGRP expression display an osteopenia caused by a decreased bone formation. These results show that alphaCGRP is a physiological activator of bone formation and that the high bone mass phenotype of the Calca-deficient mice is caused by the absence of CT.
Calcitonin (CT) and alpha-calcitonin gene-related peptide (alphaCGRP) are two polypeptides without completely defined physiologic functions that are both derived from the Calca gene by alternative splicing. We have recently described an unexpected high bone mass phenotype in mice carrying a targeted deletion of the Calca gene. To uncover whether this phenotype is caused by the absence of CT or by the absence of alphaCGRP, we analyzed a mouse model, where the production of alphaCGRP is selectively abolished.
Bones from Calca(-/-) mice, alphaCGRP(-/-) mice, and their corresponding wildtype controls were analyzed using radiography, muCT imaging, and undecalcified histology. Cellular activities were assessed using dynamic histomorphometry and by measuring the urinary collagen degradation products. CT expression was determined using radioimmunoassay and RT-PCR. Immunohistochemistry was performed using an anti-CGRP antibody on decalcified bone sections.
Unlike the Calca-deficient mice, the alphaCGRP-deficient mice do not display a high bone mass phenotype. In contrast, they develop an osteopenia that is caused by a reduced bone formation rate. Serum levels and thyroid expression of CT are not elevated in alphaCGRP-deficient mice. While CGRP expression is detectable in neuronal cell close to trabecular bone structures, the components of the CGRP receptor are expressed in differentiated osteoblast cultures.
The discrepancy between the bone phenotypes of Calca(-/-) mice and alphaCGRP(-/-) mice show that the high bone mass phenotype of the Calca(-/-) mice is caused by the absence of CT. The osteopenia observed in the alphaCGRP(-/-) mice that have normal levels of CT further show that alphaCGRP is a physiologic activator of bone formation.
我们最近在缺乏编码降钙素(CT)和α降钙素基因相关肽(αCGRP)的Calca基因的小鼠中描述了一种意外的高骨量表型。在此我们表明,特异性缺乏αCGRP表达的小鼠表现出由于骨形成减少导致的骨质减少。这些结果表明,αCGRP是骨形成的生理激活剂,并且Calca基因缺陷小鼠的高骨量表型是由CT缺失引起的。
降钙素(CT)和α降钙素基因相关肽(αCGRP)是两种生理功能尚未完全明确的多肽,它们均通过可变剪接从Calca基因衍生而来。我们最近在携带Calca基因靶向缺失的小鼠中描述了一种意外的高骨量表型。为了揭示这种表型是由CT缺失还是αCGRP缺失引起的,我们分析了一种小鼠模型,其中αCGRP的产生被选择性消除。
使用X射线摄影、微计算机断层扫描(μCT)成像和不脱钙组织学分析Calca(-/-)小鼠、αCGRP(-/-)小鼠及其相应野生型对照的骨骼。使用动态组织形态计量学并通过测量尿胶原降解产物来评估细胞活性。使用放射免疫测定和逆转录聚合酶链反应(RT-PCR)测定CT表达。在脱钙骨切片上使用抗CGRP抗体进行免疫组织化学。
与Calca基因缺陷小鼠不同,αCGRP基因缺陷小鼠未表现出高骨量表型。相反,它们出现了由骨形成率降低引起的骨质减少。αCGRP基因缺陷小鼠的血清CT水平和甲状腺CT表达未升高。虽然在靠近小梁骨结构的神经元细胞中可检测到CGRP表达,但CGRP受体的成分在分化的成骨细胞培养物中表达。
Calca(-/-)小鼠和αCGRP(-/-)小鼠骨表型之间的差异表明,Calca(-/-)小鼠的高骨量表型是由CT缺失引起的。在CT水平正常的αCGRP(-/-)小鼠中观察到的骨质减少进一步表明,αCGRP是骨形成的生理激活剂。